Abstract A worldwide effort to counter the COVID-19 pandemic has resulted in hundreds of candidate vaccines moving through various stages research and development, including several phase 1, 2 3 clinical trials. relatively small number these have been evaluated SARS-CoV-2 disease models, fewer a severe model. Here, DNA targeting spike protein delivered by jet injection, nCoV-S(JET), elicited ne...
